Purveyance are leaders for CRM solutions and B2B Marketplace Purveyance are leaders for CRM solutions and B2B Marketplace
  • HOME
  • SALES EXECUTION
    • SOFTWARE DETAIL
  • RETAILER MARKETPLACE
  • PARTNERS and TESTIMONIALS
  • ABOUT
    • MEET THE TEAM
  • CONTACT
  • BLOG
  • HOME
  • SALES EXECUTION
    • SOFTWARE DETAIL
  • RETAILER MARKETPLACE
  • PARTNERS and TESTIMONIALS
  • ABOUT
    • MEET THE TEAM
  • CONTACT
  • BLOG

Pharmacy

Home » Pharmacy » Page 3
0
By purveyancenews
In Australia, NewZealand, Pharmacy
Posted December 21, 2016

Codeine crackdown: concerns change fails to consider pain treatment and addiction

Australia’s move to limit codeine products to prescription only has sparked concerns about added medical costs, and been criticised for failing to deal with barriers to addiction and pain [...]

READ MORE
0
By purveyancenews
In Australia, NewZealand, Pharmacy
Posted December 15, 2016

The Sweet Smell of Seasonal Success

Category seasonality has always been an important consideration in retail. In recent years, however, we have seen retailers increase their efforts in maximising the opportunities particular [...]

READ MORE
0
By purveyancenews
In Australia, International, NewZealand, Pharmacy
Posted November 24, 2016

How Tech-Enabled Consumers Are Reordering the Healthcare Landscape

Healthcare companies are developing new digital technologies to give consumers more control over the care they receive. That could upend the industry’s move toward greater consolidation and [...]

READ MORE
0
By purveyancenews
In Australia, International, NewZealand, Pharmacy
Posted August 22, 2016

Best of Both Worlds: Pharmacy Growth Continues, While Online Opportunities Abound

Growth in Australian pharmacy continues to outpace the grocery and convenience channels, and this trend could persist with further development of online retailing for health and beauty [...]

READ MORE
0
By purveyancenews
In International, Pharmacy
Posted June 28, 2016

Mayne Pharma in Plunge into US Drugs Market

Mayne Pharma has moved to lift its presence in the US drugs market with the $890 million ($US652 million) acquisition of a suite of drugs from Israel’s Teva Pharmaceuticals.The buy will be [...]

READ MORE
1 2 3 4 5 6 7 8 9 ...
page 1 of 48
Sitemap | Privacy Policy | © 2018 DE DATA. All Rights Reserved. ABN: 16 078 767 521.
 

Loading Comments...